MARCH 18, 2021
Grants Awarded

Extramurally funded research grants awarded to Rogel Cancer Center members

Program Key:
CB - Cancer Biology; CG - Cancer Genetics; CHI - Cancer Hematopoiesis and Immunology; DT - Developmental Therapeutics; HBO - Health Behavior and Outcomes; CEP - Cancer Epidemiology and Prevention; TACR - Translational and Clinical Research
In the Spotlight from Cancer Biology
The Department of Defense awarded research fellow Leidy Mendoza Reinoso (mentor: Laurie McCauley, D.D.S., Ph.D.) a $305K Prostate Cancer Research Program Early Investigator Research Award for “Regulation of Prostate Skeletal Bone Metastases by TIM-3-dependent Efferocytosis”
The National Cancer Institute (NCI) awarded neurosurgery resident Michael Strong, M.D., Ph.D. (mentor: Nicholas Szerlip, M.D.) a $141K F32 for “The role of differential bone marrow immune landscape in permissive tumor growth in the spine”
$100K+ Extramural Grants Awarded in February
Other NIH

Research fellow David Hanna (mentor: Ruma Banerjee, Ph.D.): NIGMS F32 ($201K) "Sulfide metabolism at the host microbiome interface" (CB)

Other External

Richard Gonzalez, Ph.D.: $104K from Proctor and Gamble for "E=MC2 Naturals/Trust" (HBO) 
This project is about what drives people toward or away from buying products that are "organic" or "natural". The relevance to cancer is new knowledge about how to change people's behavior to avoid chemical exposures, which may eventually translate into new behavioral interventions to reduce exposure risk.

Jason Spence, Ph.D.: $140K from the Cystic Fibrosis Foundation for "Interrogating the CF in iPSC derived intestine and colon" (CB)
Rogel Cancer Center List of Internal and External Funding Opportunities
We update and maintain a comprehensive list of funding opportunities for cancer research.

Please forward this message to your fellow cancer center colleagues.